Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis [0.03%]
艾法维瑞或利福平和异烟肼与左炔诺孕酮紧急避孕药在治疗艾滋病或结核病期间的药物基因组相互作用
Nana Agyemang,Kimberly K Scarsi,Paxton Baker et al.
Nana Agyemang et al.
Objective: In AIDS Clinical Trials Group study A5375, a pharmacokinetic trial of levonorgestrel emergency contraception, double-dose levonorgestrel (3 mg, versus standard dose 1.5 mg) offset the induction effects of efavi...
N -acetyltransferase 2 haplotype modifies risks for both dyslipidemia and urinary bladder cancer [0.03%]
N-乙酰转移酶2基因型可同时改变高脂血症和尿路膀胱癌的危险性
Kyung U Hong,David W Hein
Kyung U Hong
A novel haplotype in N -acetyltransferase 2 ( NAT2 ) composed of seven non-coding variants (rs1495741, rs4921913, rs4921914, rs4921915, rs146812806, rs35246381, and rs35570672) has been linked to dyslipidemia by multiple, independent genome...
Bone marrow mesenchymal stem cell-derived exosomes carrying E3 ubiquitin ligase ITCH attenuated cardiomyocyte apoptosis by mediating apoptosis signal-regulated kinase-1 [0.03%]
骨髓间充质干细胞衍生的含ITCH泛素连接酶外泌体通过调节凋亡信号调节激酶-1减轻心肌细胞凋亡
Xuejun Li,Xuanyi Hu,Qiansu Chen et al.
Xuejun Li et al.
Background: Bone marrow mesenchymal stem cell (BMSC)-derived exosomes have been verified to perform an effective role in treating acute myocardial infarction (MI). Herein, we aimed to investigate the role of BMSC-derived ...
Mouse nerve growth factor suppresses neuronal apoptosis in valproic acid-induced autism spectrum disorder rats by regulating the phosphoinositide-3-kinase/serine/threonine kinase signaling pathway [0.03%]
鼠神经生长因子通过调节磷脂酰肌醇-3-激酶/蛋白 Ser/Thr 激酶信号通路抑制丙戊酸诱导的自闭症模型大鼠神经元凋亡
Jie Jian,Li-Guo Li,Peng-Ju Zhao et al.
Jie Jian et al.
Background: Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by deficits in social communication and restrictive behaviors. Mouse nerve growth factor (mNGF), a neurotrophic factor, i...
Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans [0.03%]
南非艾滋病阳性人群替诺福韦肾毒性的药物基因组学研究
Somila Mateza,Yuki Bradford,Gary Maartens et al.
Somila Mateza et al.
Objective: Renal toxicity is more common with tenofovir disoproxil fumarate (TDF) than with tenofovir alafenamide fumarate (TAF). We investigated whether polymorphisms in genes relevant to tenofovir disposition affect ren...
Randomized Controlled Trial
Pharmacogenetics and genomics. 2023 Jul 1;33(5):91-100. DOI:10.1097/FPC.0000000000000491 2023
'Effect of CYP2C19 genetic variants on bleeding and major adverse cardiovascular events in a cohort of Arab patients undergoing percutaneous coronary intervention and stent implantation' by Ali et al. - reassess the evidence, shall we? [0.03%]
阿里等关于“CYP2C19基因变异对阿拉伯人经皮冠状动脉介入治疗和支架植入患者的出血和主要不良心血管事件的影响”——我们有必要重新评估证据吗?
Miriam Saiz-Rodríguez,Pablo Zubiaur,Francisco Abad-Santos
Miriam Saiz-Rodríguez
Pharmacogenetics of tenofovir clearance among Southern Africans living with HIV [0.03%]
南方非洲艾滋病病毒感染者体内替诺福韦清除的药物基因组学研究
Zinhle Cindi,Aida N Kawuma,Gary Maartens et al.
Zinhle Cindi et al.
Background: Tenofovir is a component of preferred combination antiretroviral therapy (ART) regimens in Africa. Few pharmacogenetic studies have been conducted on tenofovir exposure in Africa, where genetic diversity is gr...
Randomized Controlled Trial
Pharmacogenetics and genomics. 2023 Jun 1;33(4):79-87. DOI:10.1097/FPC.0000000000000495 2023
Associations between four polymorphisms of the SLCO1B1 and effectiveness of the statins: a meta-analysis [0.03%]
SLCO1B1基因多态性与他汀类药物疗效的关联:一项系统评价和meta分析
Hong Ha Nguyen,Cuc Thi Thu Nguyen,Tran Ngoc Phuong Mai et al.
Hong Ha Nguyen et al.
Objective: Statins are the first-choice therapy for dyslipidemia, but their effectiveness can be influenced by genetic polymorphisms. This study was conducted to assess the association of variants of the solute carrier an...
Nabil E Omar,Hazem Elewa
Nabil E Omar
With the scarcity of pharmacological otoprotective agents against cisplatin-induced ototoxicity (CIO), researchers find themselves compelled to look at and navigate all possible strategies to identify ways to prevent CIO. One of these promi...
Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation [0.03%]
CYP3A5基因型对肾移植病人他克莫司药物用量及用药监测的影响
Nikhil Rao,Taylor Carcella,Neha Patel et al.
Nikhil Rao et al.
Objectives: LCP tac has a recommended starting dose of 0.14 mg/kg/day in kidney transplant. The goal of this study was to assess the influence of CYP3A5 on perioperative LCP tac dosing and monitoring. ...
Observational Study
Pharmacogenetics and genomics. 2023 Apr 1;33(3):59-65. DOI:10.1097/FPC.0000000000000494 2023